Qiagen flags press release on molecular testing solutions for rising US Cyclospora outbreak - QGEN News | RalliesQiagen flags press release on molecular testing solutions for rising US Cyclospora outbreak
Q
QGEN• Qiagen highlights molecular testing products for Cyclospora response
- Qiagen published a press release highlighting molecular testing products supporting the U.S. response to a growing Cyclospora outbreak.
- The release cites more than 1,600 confirmed U.S. cyclosporiasis cases since May 2026, with about 7,000 potential cases under investigation.
- Qiagen flagged its FDA-cleared QIAstat-Dx Gastrointestinal Panel 2, which detects Cyclospora in about an hour as part of a 16-target menu.
- It also pointed to QIAcuity digital PCR and QIAseq NGS tools for research and public health investigations.
- More information is available at www.qiagen.com.
SMHI
•
